Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues.
In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients.
Back in June, CMS proposed significant updates to its current TAVR policies. Three leading healthcare societies have now joined forces to share their own perspective on the potential updates.
Cardiologists and vascular surgeons were previously told they could still use the device if necessary. Now, however, the message is that they should return the product to the manufacturer.
When patients take semaglutide, you can't necessarily predict the cardiovascular impact by tracking weight loss. A lot of it appears to comes down to the dose.
Many heart patients who would benefit from TAVR are still missing out on the care they need. AI, it turns out, can help cardiologists find those patients. An upcoming webinar is set to explore this topic at length.
Trace amounts of blood were identified within the sealed packaging of these devices. No patients were exposed to the foreign material, and no adverse events were reported, but Medtronic is recalling the devices as a precaution.
Enlicitide, the new oral PCSK9 inhibitor from Merck, will be sold under the brand name Lipfendra. It is approved to reduce LDL-C in patients with hypercholesterolemia, including HeFH.
